Zobrazeno 1 - 8
of 8
pro vyhledávání: '"SoliMix Trial Investigators"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
null Philip D. Home, null Rory J. McCrimmon, null Julio Rosenstock, null Matthias Blüher, null Katrin Pegelow, null Lydie Melas‐Melt, null Khier Djaballah, null Francesco Giorgino, null the SoliMix trial investigators
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d68e8d570a2f53dc8df75c0792d2129c
https://doi.org/10.1111/dom.14907/v2/response1
https://doi.org/10.1111/dom.14907/v2/response1
Autor:
the SoliMix Trial Investigators, Rory J. McCrimmon, Nacima Demil, Mireille Bonnemaire, Pascaline Picard, Agustina Alvarez, Nebojsa Lalic, Saud Al Sifri, Carlos Trescolí, Viswanathan Mohan, Leobardo Sauque-Reyna, Rifat Emral, Julio Rosenstock
Objective: To directly compare the efficacy and safety of a fixed-ratio combination, iGlarLixi, with a premix insulin analog (BIAsp 30) as treatment advancement in type 2 diabetes suboptimally controlled on basal insulin plus oral antihyperglycemic d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c96d1eadb970a5c6df8e22ceb0e0a32
https://doi.org/10.2337/figshare.14754426.v2
https://doi.org/10.2337/figshare.14754426.v2
Autor:
SoliMix Trial investigators, Mireille Bonnemaire, Saud Al Sifri, Rory J. McCrimmon, Mathieu Coudert, Viswanathan Mohan, Carlos Trescoli, Nacima Demil, Agustina Alvarez, Leobardo Sauque-Reyna, Julio Rosenstock, Alka Shaunik, Nebojsa Lalic, Rifat Emral
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 23(6)
Aim Premix insulin is commonly used in some regions of the world, despite the higher risk of hypoglycaemia and weight gain compared with basal insulin, based on the premise that it offers a simplified insulin regimen. iGlarLixi is a once-daily titrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2917a684635075227faa47a28ff8f8
https://pubmed.ncbi.nlm.nih.gov/34463418
https://pubmed.ncbi.nlm.nih.gov/34463418
Autor:
Nacima Demil, Carlos Trescoli, Alka Shaunik, Julio Rosenstock, SoliMix Trial investigators, Rory J. McCrimmon, Rifat Emral, Mireille Bonnemaire, Saud Al Sifri, Mathieu Coudert, Agustina Alvarez, Nebojsa Lalic, Viswanathan Mohan, Leobardo Sauque-Reyna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fabef3884c1ec455b6889cde7732a06
https://doi.org/10.1111/dom.14354/v2/response1
https://doi.org/10.1111/dom.14354/v2/response1
Autor:
McCrimmon R, Al Sifri S, Emral R, Mohan V, Sauque-Reyna L, Trescoli C, Lalic N, Alvarez A, Demil N, Coudert M, Shaunik A, Bonnemaire M, Rosenstock J, SoliMix Trial Investigators
Publikováno v:
DIABETES OBESITY & METABOLISM
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Aim Premix insulin is commonly used in some regions of the world, despite the higher risk of hypoglycaemia and weight gain compared with basal insulin, based on the premise that it offers a simplified insulin regimen. iGlarLixi is a once-daily titrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::fc3c1ba9523f1b9df9248570e337d240
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10763
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10763
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rosenstock, Julio, Emral, Rifat, Sauque-Reyna, Leobardo, Mohan, Viswanathan, Trescoli, Carlos, Al Sifri, Saud, Lalic, Nebojsa, Alvarez, Agustina, Picard, Pascaline, Bonnemaire, Mireille, Demil, Nacima, McCrimmon, Rory J., Trescolí, Carlos, Sifri, Saud Al, SoliMix Trial Investigators
Publikováno v:
Diabetes Care; Oct2021, Vol. 44 Issue 10, p2361-2370, 10p, 1 Chart, 3 Graphs